Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. N Engl J Med. 2022 11 03; 387(18):1649-1660.
View in:
PubMed
subject areas
Adolescent
Adult
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Child
Cyclophosphamide
Doxorubicin
Etoposide
Hodgkin Disease
Humans
Neoplasm Recurrence, Local
Prednisone
Treatment Outcome
Vincristine
authors with profiles
Tara O. Henderson